JAMA Oncology : Discontinuation of Tyrosine Kinase Inhibitors for Patients With Chronic Myeloid Leukemia

Interview with Ehab Atallah, MD, author of Assessment of Outcomes After Stopping Tyrosine Kinase Inhibitors Among Patients With Chronic Myeloid Leukemia: A Nonrandomized Clinical Trial

Source: JAMA Specialty Journals Author Interviews - November 12, 2020 Category: General Medicine Authors: The JAMA Network Source Type: podcasts